Cargando…
Natural Compounds: Potential Therapeutics for the Inhibition of Cartilage Matrix Degradation in Osteoarthritis
Osteoarthritis (OA) is the most common degenerative joint disease characterized by enzymatic degradation of the cartilage extracellular matrix (ECM) causing joint pain and disability. There is no disease-modifying drug available for the treatment of OA. An ideal drug is expected to stop cartilage EC...
Autores principales: | Ashruf, Omer S., Ansari, Mohammad Yunus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866583/ https://www.ncbi.nlm.nih.gov/pubmed/36676051 http://dx.doi.org/10.3390/life13010102 |
Ejemplares similares
-
Inhibition of fibroblast activation protein ameliorates cartilage matrix degradation and osteoarthritis progression
por: Fan, Aoyuan, et al.
Publicado: (2023) -
Targeting Cartilage Degradation in Osteoarthritis
por: McClurg, Oliver, et al.
Publicado: (2021) -
Aggrecanases and cartilage matrix degradation
por: Nagase, Hideaki, et al.
Publicado: (2003) -
Sanmiao formula inhibits chondrocyte apoptosis and cartilage matrix degradation in a rat model of osteoarthritis
por: XU, YING, et al.
Publicado: (2014) -
Tongbi Huoluo Decoction alleviates cartilage degeneration in knee osteoarthritis by inhibiting degradation of extracellular matrix
por: Chen, Weijian, et al.
Publicado: (2023)